Garlic and Ampyra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Garlic (allium sativum) and Ampyra (dalfampridine). Common drug interactions include convulsion among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Garlic and Ampyra. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Garlic?

Garlic has active ingredients of allium sativum. It is often used in heart health. eHealthMe is studying from 2,714 Garlic users. Check the latest studies of Garlic.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.



On Jul, 26, 2026

16 people who take Garlic and Ampyra together, and have interactions are studied.

Garlic and Ampyra drug interactions.

What are the common drug interactions of Garlic and Ampyra, by gender? *:

female:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Skin disorder (skin disease)
  3. Dizziness
  4. Pruritus (severe itching of the skin)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nausea (feeling of having an urge to vomit)
  7. Xerosis (abnormal dryness of the skin or mucus membranes)
  8. Abdominal pain upper
  9. Acne (skin problems that cause pimples)
  10. Drug hypersensitivity

male:

  1. Drug ineffective
  2. Surgery
  3. Insomnia (sleeplessness)
  4. Nausea (feeling of having an urge to vomit)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pruritus (severe itching of the skin)
  7. Restlessness (not able to rest)
  8. Skin burning sensation
  9. Throat irritation
  10. Urinary tract infection

What are the common drug interactions of Garlic and Ampyra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Dizziness
  3. Eye injury
  4. Fall

30-39:

n/a

40-49:

  1. Blood potassium decreased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Dizziness
  4. Drug specific antibody present
  5. Dyskinesia (abnormality or impairment of voluntary movement)
  6. Influenza like illness
  7. Nausea (feeling of having an urge to vomit)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Urinary tract infection

50-59:

  1. Asthenia (weakness)
  2. Blood pressure diastolic decreased
  3. Blood pressure systolic increased
  4. Gastric ulcer (stomach ulcer)
  5. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  6. Insomnia (sleeplessness)
  7. Limb injury
  8. Neuralgia (pain in one or more nerves)
  9. Oedema peripheral (superficial swelling)
  10. Oesophageal ulcer (ulcer of oesophagus)

60+:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. White blood cell count decreased
  3. Balance disorder
  4. Dizziness
  5. Dyspepsia (indigestion)
  6. Loss of consciousness
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Vertigo

What are the existing conditions these people have? *

  1. Gait Disturbance: 3 people, 18.75%
  2. Stress And Anxiety: 1 person, 6.25%
  3. Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 6.25%
  4. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 6.25%
  5. Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
  6. Muscle Spasms (muscle contraction): 1 person, 6.25%
  7. Fatigue (feeling of tiredness): 1 person, 6.25%
  8. Acne (skin problems that cause pimples): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Garlic and Ampyra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Garlic and Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Garlic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Garlic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ampyra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on allium sativum and dalfampridine (the active ingredients of Garlic and Ampyra, respectively), and Garlic and Ampyra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: